Eastwood Bio-Medical Canada Inc. reported earnings results for the first quarter ended January 31, 2022. For the first quarter, the company reported sales was CAD 0.306543 million compared to CAD 0.183895 million a year ago. Revenue was CAD 0.331012 million compared to CAD 0.199249 million a year ago.

Net loss was CAD 0.010336 million compared to CAD 0.191559 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.